Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
for Advanced Malignant Solid Neoplasm
Sites in Irvine, Orange +13 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT05691491·Phase 1, Phase 2·Recruiting·Listed Jan 2023